Jessie Elliott

Affiliation(s):
Trinity College Dublin; St James's Hospital;

Department:
Department of Surgery, Trinity St. James's Cancer Institute

Research interests:
Fertility, Cancer, HRT

PubMed profile:
https://www.researchgate.net/profile/Jessie-Elliott

ORCID Profile:
https://orcid.org/0000-0003-4673-0386

Biography

Jessie Elliott is an Upper Gastrointestinal Surgeon and Academic Lead at the National Centre for Oesophageal and Gastric Cancer, Trinity St. James's Cancer Institute in Dublin, Ireland, focused on treating patients with oesophageal and gastric cancer. She has a special interest in minimally invasive and robotic surgery, and clinical trials in upper gastrointestinal cancer. 

She studied at Trinity College Dublin and completed a PhD in translational medicine at University College Dublin, investigating novel strategies to enhance nutrition in cancer survivorship, before completing postgraduate surgical training. She undertook international fellowships in robotic upper gastrointestinal cancer surgery at the University Medical Centre, Utrecht, the Netherlands, and in gastric cancer surgery at Seoul National University Hospital, South Korea. 

She leads a clinical and translational research group in oesophageal and gastric cancer survivorship at the Trinity St James’s Cancer Institute. She has received a number of awards for her work including the American College of Surgeons International Scholarship, European Society for Diseases of the Esophagus Fellowship, and an ASCO Conquer Cancer Award. Current funders include the Irish Cancer Society and Health Research Board. 

She holds leadership positions including Co-Chair of the UK and Ireland Oesophagogastric Cancer Research Group and Editor of Diseases of the Esophagus journal. She is passionate about the delivery of impactful clinical and translational research to address key questions and improve care for people living with and beyond upper gastrointestinal cancer.

Publications:

1. Barman S, Chevallay M, Gisbertz SS, Van Hemelrijck M, Byrne BE, Wijnhoven B, Markar SR, Elliott JA, et al. EUropean consensus on the Resolution Of SympToms After Oesophago-gastric Resection (EUROSTAR) – A Peri-operative Quality Initiative (POQI) consensus statement. Gut. 2026

2. CM Jones, WH Ng, L Tincknell, DP McClurg, E Adam, P Bhandari, K Campbell, P Chambers, FD Ciccarelli, HG Coleman, TDL Crosby, C Doyle, J Dunn, JA Elliott, et al Research priorities for cancers of the oesophagus and stomach: recommendations from a United Kingdom & Ireland patient and healthcare professional partnership exercise. Gut. 2025

3. JA Elliott, F Klevebro, S Mantziari, SR Markar, L Goense, A Johar, P Lagergren, G Zaninotto, R van Hillegersberg, MI van Berge Henegouwen, M Schäfer, M Nilsson, GB Hanna, JV Reynolds, ENSURE Study Group. Neoadjuvant chemoradiotherapy versus chemotherapy for the treatment of locally advanced esophageal adenocarcinoma in the European multicenter ENSURE study. Annals of Surgery. 2024

4. JA Elliott, SR Markar, F Klevebro, A Johar, L Goense, P Lagergren, G Zaninotto, R van Hillegersberg, MI van Berge Henegouwen, M Nilsson, GB Hanna, JV Reynolds, ENSURE Study Group. An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE). Annals of Surgery. 2022

5. JA Elliott, NG Docherty, CF Murphy, H-G Eckhardt, SL Doyle, EM Guinan, N Ravi, JV Reynolds, CW le Roux. Changes in gut hormones, glycaemic response and symptoms after oesophagectomy. British Journal of Surgery. 2019